publication date: Jan. 24, 2014
20140124 - Jan. 24, 2014
ISSUE 4 – JAN. 24, 2014PDF

Conversation with The Cancer Letter:
Seffrin To Retire After Restructuring ACS

The American Cancer Society has started a search to replace its chief executive officer, John Seffrin.

Seffrin, who became the CEO in 1992, recently completed streamlining of the society’s organizational structure, eliminating the autonomy of divisions, decreasing the number of board members, and making the century-old organization into a single corporate entity.

photoASCO, COA Present Plans For Cancer Care
Beyond the Fee-for-Service Pay Structure

The Community Oncology Alliance and the American Society of Clinical Oncology issued a joint statement on payment reform in cancer care and proposed alternative approaches to paying for cancer care. 

photoKomen Officials Say Charity is Stabilizing Despite 22 Percent Drop in Contributions

The Susan G. Komen Breast Cancer Foundation reported a 22 percent decline in contributions in fiscal 2013—totalling over $77 million—in recent financial statements.

Overall, the charity’s revenues fell by 18 percent from the 2012 fiscal year.

photoFDA News

  • Reagent system approved for the prevention of Graft-Versus-Host Disease

  • FDA launches advisory committee membership nomination web portal 

  • Orphan designation granted to BL-8040 for stem cell mobilization

  • EU CHMP issues positive opinion for Roche’s subcutaneous MabThera

Copyright (c) 2020 The Cancer Letter Inc.